A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
Clinical trial NCT02532283 · COMPLETED
Trial details
- NCT number
- NCT02532283
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-11
- Primary completion
- 2017-02-24
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.